Humana To Rally Over 14%? Here Are 5 Other Price Target Changes For Thursday

SVB Leerink raised Humana Inc. HUM price target from $540 to $640. SVB Leerink analyst Whit Mayo maintained the stock with an Outperform rating. Humana shares rose 0.9% to close at $559.58 on Wednesday.
Needham cut the price target on STAAR Surgical Company STAA from $110 to $83. Needham analyst David Saxon maintained a Buy rating on the stock. STAAR Surgical shares fell 9.4% to $64.00 in pre-market trading.
HC Wainwright & Co. lowered Surface Oncology, Inc. SURF price target from $8.5 to $6. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating on the stock. Surface Oncology shares fell 4.4% to close at $1.29 on Wednesday.
Raymond James cut Broadridge Financial Solutions, Inc. BR price target from $189 to $180. Raymond James analyst Patrick O'Shaughnessy maintained an Outperform rating on the stock. Broadridge Financial fell 7.9% to close at $137.73 on Wednesday.
DA Davidson boosted e.l.f. Beauty, Inc. ELF price target from $44 to $54. DA Davidson analyst Linda Bolton Weiser maintained a Buy rating on the stock. e.l.f. Beauty shares rose 11.6% to $46.50 in pre-market trading.
Telsey Advisory Group slashed The Estée Lauder Companies Inc. EL price target from $377 to $275. Telsey Advisory Group analyst Dana Telsey maintained an Outperform rating on the stock. Estée Lauder shares fell 0.4% to $189.25 in pre-market trading.